In the current study, we found that CD73 activates the p38–STAT1 axis through tumor cell-autocrine adenosine–Adora2a signaling, which results in the upregulation of CCL5 and further Treg recruitment in pancreatic cancer. This evidence concerns the gene ADORA2A and familial pancreatic carcinoma.